Download PDF
Semin Reprod Med 1997; 15(2): 111-122
DOI: 10.1055/s-2007-1016294
Copyright © 1997 by Thieme Medical Publishers, Inc.

Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome, and Its Clinical Implications

John E. Nestler
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical College of Virginia/Virginia Commonwealth University, Richmond, Virginia
Further Information

Publication History

Publication Date:
15 March 2008 (online)

  PDF Download  Permissions and Reprints

Abstract

The polycystic ovary syndrome (PCOS) is a prevalent disorder affecting approximately 6% of women of reproductive age, and is characterized by anovulation and hyperandrogenism. It has also become apparent that a frequent feature of women with PCOS is insulin resistance accompanied by compensatory hyperinsulinemia, and increasing evidence suggests that hyperinsulinemia plays an important role in the pathogenesis of PCOS.

This article will review (1) evidence indicating that insulin contributes to the hyperandrogenism of PCOS by stimulating ovarian androgen production and decreasing serum sex hormone-binding globulin (SHBG) concentrations; (2) possible direct effects of hyperinsulinemia on folliculogenesis; (3) the relationship between insulin and adrenal androgens in women; and (4) therapeutic and clinical implications of these findings.

Keywords:

Polycystic ovary syndrome - insulin - insulin resistance - androgens - ovulation

      >